RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $125

Benzinga · 5d ago
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $135 to $125.